Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics
Open accessPublished version of a preprint
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; none of the 76 sources its claims cite is checked for support yet.
Abstract
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset disease caused by modest alanine expansion at the amino terminus of the nuclear polyadenosine RNA binding protein PABPN1. PABPN1 is expressed ubiquitously and is involved in multiple steps in RNA processing including optimal cleavage and polyadenylation, polyadenylation signal selection, and export of polyadenylated RNAs from the nucleus. Expanded PABPN1 forms aggregates in a subset of muscle nuclei, but PABPN1 levels are paradoxically low in muscle compared to other tissues. Despite several studies in model systems and patient tissues, it remains unclear whether alanine expansion directly impairs PABPN1 function. The molecular mechanisms leading to OPMD pathology are poorly understood. Here we used a proximity labeling approach to better understand the effect of alanine expansion on PABPN1 function in a cell culture model of skeletal muscle. To avoid the confounding factor of overexpression, PABPN1 constructs containing a carboxy-terminal TurboID tag were expressed in skeletal myotubes at near native levels using an inducible promoter. Although non-expanded PABPN1-TurboID was able to complement RNA export and myoblast differentiation defects caused by deficiency of endogenous PABPN1, alanine expanded PABPN1-TurboID was not. Comparative proteomics revealed increased interaction between expanded PABPN1 and RNA splicing and polyadenylation machinery and follow-up studies identified a dominant negative effect of expanded PABPN1 on RNA export in differentiated myotubes. These data indicate that alanine expansion can impair PABPN1 function regardless of the presence of wild type PABPN1 and support a model wherein both loss function and dominant negative effects of expanded PABPN1 contribute to OPMD pathology.
Overview
CoChat Summary
TL;DR
Alanine-expanded PABPN1 (Ala17) expressed at near-native levels in C2C12 myotubes fails to fully complement PABPN1 loss and exerts dominant negative effects on RNA export and differentiation. Proximity labeling and comparative proteomics show Ala17 PABPN1 has increased interactions with splicing/polyadenylation and ubiquitin-proteasome proteins, reduced stability, and reduced interaction with nuclear export machinery.
Key findings
- Ala10 PABPN1-TurboID reversed nuclear poly(A) RNA accumulation and restored myotube fusion in Pabpn1 knockdown cells, whereas Ala17 PABPN1-TurboID did not fully rescue these phenotypes; both rescued the reduced nuclei/survival phenotype.
- Ala17 PABPN1-TurboID caused a dominant negative effect: reduced fusion index in control myotubes, increased nuclear poly(A) RNA accumulation at near-native and overexpression levels, and nuclear accumulation of the Tnnt3 transcript; primary myotubes from Pabpn1+/A17 mice also showed reduced cytoplasmic poly(A) RNA signal.
- Proteomics identified 595 proteins at FDR ≥95%; 130 proteins in Ala10 and 142 in Ala17 PABPN1-TurboID eluates, with 6 unique to Ala10 and 18 unique to Ala17. Ala17-enriched proteins included RNA splicing/polyadenylation and ubiquitin-proteasome components, e.g., NUDT21 fold change 2.24, ZC3H14 2.08, UBE2D3 2.64, while NUP214 was lower in Ala17.
- Cycloheximide chase showed half-lives of ~10 h for endogenous PABPN1, ~15 h for Ala10 PABPN1-TurboID, and ~2 h for Ala17 PABPN1-TurboID; endogenous PABPN1 half-life was reduced in Ala17-expressing cells, and Ala17 showed reduced interaction with THOC5.
Methods
- Stable C2C12 myoblast lines expressing doxycycline-inducible Ala10 or Ala17 PABPN1-TurboID were differentiated into myotubes and induced to near-native levels (~50% of endogenous PABPN1), then treated with biotin for proximity labeling.
- Functional assays included Pabpn1 siRNA knockdown/rescue, immunofluorescence, oligo d(T) FISH, subcellular fractionation, qPCR of fractionated myotubes, cycloheximide chase, streptavidin precipitation, and THOC5 co-immunoprecipitation.
- Comparative proteomics used label-free nanoLC-MS/MS on streptavidin-captured biotinylated proteins from three independent experiments, with strict filtering (detected in ≥2/3 replicates and not in wild type) and STRING functional annotation.
Limitations
- Stated: the use of C2C12 myotubes is a limitation; some PABPN1 functions, such as DNA double-strand break repair, were not represented, and effects may differ by differentiation state and muscle group.
- Stated: proteomics cannot distinguish Ala10 PABPN1-TurboID sequence from endogenous PABPN1, and no PABPN1 aggregates were detected in myotubes, possibly because expanded PABPN1 was expressed for only 48 hours.
- Evident from the text: near-native expression was defined as ~50% of endogenous PABPN1 rather than exactly one allele; the C-terminal TurboID tag led to some additional cytosolic PABPN1-TurboID signal; strict proteomics cutoffs may miss low-abundance or transient interactors.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
0 Valid · 0 Not valid · 48 Not checked · 95 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Subcellular fractionation and immunoblot indicated that PABPN1-TurboID can be detected in both nuclear and cytoplasmic compartments in myotubes (Fig 2A).”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Functional characterization of PABPN1-TurboID constructs
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
In the paper
“Interestingly, myoblast growth was significantly reduced upon expression of Ala17 PABPN1-TurboID in negative control (siScr) or Pabpn1 knockdown (siPabpn1) myoblasts as detected by nuclei count (Fig 3B), which is consistent with the reduced proliferation detected in pharyngeal myoblasts from the Pabpn1+/A17 knock-in mouse in vivo and in vitro [29].”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Functional characterization of PABPN1-TurboID constructs
What the sources say
- Not checked yetcites [29] Zhang Y, Zeuthen C, Zhu C, Wu F, Mezzell AT, Whitlow TJ, et al. Pharyngeal pathology in a mouse model of oculopharyngeal muscular dystrophy is associated with impaired basal autophagy in myoblasts. Front Cell Dev Biol. 2022; 10: 986930. doi: 10.3389/fcell.2022.986930 36313551 PMC9614327 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fluorescent in situ hybridization (FISH) using oligo-deoxythymidine [oligo d(T)] nucleotide probes suggested that bulk polyadenylated RNA is retained in the nucleus in C2C12 myotubes expressing Ala17 PABPN1-TurboID and in primary myotubes generated from the Pabpn1+/A17 mouse model of OPMD.”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Introduction
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunofluorescence staining of induced myotubes using an antibody to PABPN1 revealed that total PABPN1 (representing endogenous and TurboID constructs) was distributed normally with most signal in the nucleus and some signal in the cytosol (Figs 2D and S2A).”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Functional characterization of PABPN1-TurboID constructs
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
In the paper
“Importantly, expression of Ala17 PABPN1-TurboID was confirmed in immunoblots of streptavidin elutions from induced myotubes using an antibody targeting the alanine expansion (Figs 1E and S1E) [27].”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Generation of stable cell lines encoding inducible PABPN1-TurboID constructs
What the sources say
- Not checked yetcites [27] Vest KE, Apponi LH, Banerjee A, Pavlath GK, Corbett AH. An Antibody to Detect Alanine-Expanded PABPN1: A New Tool to Study Oculopharyngeal Muscular Dystrophy. J Neuromuscul Dis. 2015; 2(4): 439– 46. doi: 10.3233/JND-150111 27858752 PMC5207656 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
59 more claims
Create a free account to see all 143 claims and to verify the 76 references still open.
- It may state two separate claims as one. 57
- Probably not a substantial claim. 31
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Effect of alanine expansion of PABPN1 function
“Proteomics data suggest that Ala17 PABPN1-TurboID interacts more strongly with proteins related to protein catabolism including the E2 ubiquitin conjugating ligase UBE3D2 (Fig 4F, Tables 1 and S2).”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Identification of Ala10 and Ala17 PABPN1 proximal proteins using TurboID
“| Ala17 PABPN1 > Ala10 PABPN1 | UBE2D3 | 2478243.693 | 6551990.026 | 2.64 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Ala10 PABPN1 > Ala17 PABPN1 | STEAP3 | 9441285.084 | 2654244.135 | -1.830682168 |”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Identification of Ala10 and Ala17 PABPN1 proximal proteins using TurboID
Reported -1.830682168 · recomputed 0.281132
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Identification of Ala10 and Ala17 PABPN1 proximal proteins using TurboID
“B) Proximal proteins detected in all three Ala10 or Ala17 PABPN1 replicates but not in WT samples revealed similar numbers of putative interacting proteins for both constructs and 6 and 18 being unique to Ala10 and Ala17 PABPN1-TurboID, respectively.”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Identification of Ala10 and Ala17 PABPN1 proximal proteins using TurboID
“comparisons were performed on proteins that were detected in at least two of three independent experiments for Ala10 or Ala17 PABPN1-TurboID expressing myotubes but were not detected in wild type control samples.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Ala10 PABPN1 > Ala17 PABPN1 | NUP214 | 2821340.561 | 1969632.135 | -0.698119243 |”
§ Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics > Results > Identification of Ala10 and Ala17 PABPN1 proximal proteins using TurboID
Reported -0.698119243 · recomputed 0.698119
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., Gable, A. L., Fang, T., Doncheva, N. T., Pyysalo, S., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1000 · Cited by 9,726
Efficient proximity labeling in living cells and organisms with TurboID
Branon, T. C., Bosch, J. A., Sanchez, A. D., Udeshi, N. D., Svinkina, T., Carr, S. A., Feldman, J. L., Perrimon, N., & Ting, A. Y. (2018) · Nature Biotechnology · doi:10.1038/nbt.4201 · Cited by 2,174
CellProfiler 4: improvements in speed, utility and usability
Stirling, D. R., Swain-Bowden, M. J., Lucas, A. M., Carpenter, A. E., Cimini, B. A., & Goodman, A. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04344-9 · Cited by 2,070
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy
Brais, B., Bouchard, J.-P., Xie, Y.-G., Rochefort, D. L., Chrétien, N., Tomé, F. M. S., Lafrentére, R. G., Rommens, J. M., Uyama, E., Nohira, O., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-164 · Cited by 805
Evidence for a Pioneer Round of mRNA Translation
Ishigaki, Y., Li, X., Serin, G., & Maquat, L. E. (2001) · Cell · doi:10.1016/s0092-8674(01)00475-5 · Cited by 582
The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites
Jenal, M., Elkon, R., Loayza-Puch, F., van Haaften, G., Kühn, U., Menzies, F. M., Vrielink, J. A. F. O., Bos, A. J., Drost, J., Rooijers, K., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.022 · Cited by 339
Wahle, E. (1991) · Cell · doi:10.1016/0092-8674(91)90119-j · Cited by 299
Identification of a Nuclear Exosome Decay Pathway for Processed Transcripts
Meola, N., Domanski, M., Karadoulama, E., Chen, Y., Gentil, C., Pultz, D., Vitting-Seerup, K., Lykke-Andersen, S., Andersen, J. S., Sandelin, A., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.025 · Cited by 290 · cited 1×
“PABPN1 also participates in other steps of RNA processing including RNA decay [11], terminal intron splicing [12], and regulation of transcripts containing retained introns [13].”
Research works printed but not linked: 1
- Trollet C. Oculopharyngeal Muscular Dystrophy. In: Adam MP, et al. editors. GeneReviews. Seattle, Seattle (WA): University of Washington; 1993.
Cited by
Ferguson, N., Zhang, Y., Perez, A. M., Mezzell, A. T., Fivush, J. D., Shanbhag, V., Petris, M. J., & Vest, K. E. (2026) · Molecular and Cellular Biology · doi:10.1080/10985549.2026.2621941 · Cited by 3
Self-citationRecent progress in emerging therapeutics and evaluation of oculopharyngeal muscular dystrophy
Oelbrandt, F., Voermans, N., & Warman‐Chardon, J. (2026) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001508 · Cited by 1
Miao, Q., Gao, R., Huang, M., Wang, G., Wang, W., & Luo, M. B. (2026) · Bone Research · doi:10.1038/s41413-026-00578-6
From chromatin to proteostasis: multilevel gene regulation in Mendelian diseases
Goel, H., & Garg, G. (2026) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2026.1944086
Perez, A. M., Fivush, J. D., Cordill, B. M., Ferguson, N., Zhang, Y., Mezzell, A. T., Johnson, I., Mattam, U., Chaudhry, O., Porter, K., et al. (2026) · Journal of Biological Chemistry · doi:10.64898/2026.06.03.729837
Self-citation
Metadata
- Authors
- Mezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E.
- Affiliations
- University of Cincinnati (US)
- Corresponding author
- Vest, Katherine E.
- Venue
- PLOS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2026-01-26
- Volume
- 22
- Issue
- 1
- Pages
- e1011743
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC12858073
- OpenAlex
- W7125712847
- Semantic Scholar
- 02462f88aa3295257acefa7c96444e7490682c54
- Cited by
- 7
- References
- 53
- Citations by year
- 2026: 7
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Update notices
- new_version (2026-01-30)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Foundation for the National Institutes of Health (R35GM146878)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- oculopharyngeal muscular dystrophy, PABPN1, RNA export, polyadenylation, RNA splicing, dominant negative effect, loss of function, skeletal muscle myotubes, myogenesis, protein-protein interaction, proximity labeling
- MeSH terms
- Alanine, Animals, Cell Nucleus, Humans, RNA-Binding Proteins, Muscle, Skeletal, Polyadenylation, Poly(A)-Binding Protein I, Muscular Dystrophy, Oculopharyngeal, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics. https://app.cochat.ai/papers/10.1371/journal.pgen.1011743
- The paper
- Mezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E. (2026). Oculopharyngeal muscular dystrophy (OPMD) associated alanine expansion impairs the function of the nuclear polyadenosine RNA binding protein PABPN1 as revealed by proximity labeling and comparative proteomics. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011743
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.